Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹48 Cr₹37 Cr₹6.13 Cr₹197 Cr₹1.97 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹48 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr
Mar2020₹197 Cr
Mar2019₹1.97 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr
-96.88
Mar2020 ₹197 Cr
9,899.49
Mar2019 ₹1.97 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹713.5 Cr 4.6% 12.2% 23.1% Stock Analytics
ADANI ENTERPRISES ₹348,869.0 Cr 0.8% 1.3% 62.1% Stock Analytics
REDINGTON ₹16,491.5 Cr -0.5% -4.5% 20.4% Stock Analytics
HONASA CONSUMER ₹13,381.6 Cr -2.4% 6.2% NA Stock Analytics
MMTC ₹11,224.5 Cr 5.4% 6.2% 147.3% Stock Analytics
MSTC ₹6,683.8 Cr 14.8% 12.2% 211.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

4.6%

12.2%

23.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses